Jorey Chernett
CIK: 0002042077
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (50 total)
- Oct 30, 2026STIM
Neuronetics, Inc.
Purchase(P)Direct18K shares at avg. $2.27$41K - Oct 19, 2026XGN
EXAGEN INC.
Purchase(P)Direct14K shares at avg. $7.46$104K - Aug 14, 2026STIM
Neuronetics, Inc.
Purchase(P)Direct14K shares at avg. $3.16$44K - Aug 14, 2026STLN
Starling Oncology, Inc.
Purchase(P)Direct12K shares at avg. $6.54$78K - Aug 13, 2026STIM
Neuronetics, Inc.
Sale(S)DirectCall Option (STIM 19FEB27 $5C)
100 shares at avg. $3.21- - Aug 13, 2026STLN
Starling Oncology, Inc.
Sale(S)DirectCall Option (STLN 19FEB27 $9C)
100 shares at avg. $6.24- - Jul 21, 2026TOI
Oncology Institute, Inc.
Purchase(P)Direct18K shares at avg. $5.27$95K - Jul 14, 2026STIM
Neuronetics, Inc.
Purchase(P)Direct35K shares at avg. $1.78$62K - Jul 10, 2026TOI
Oncology Institute, Inc.
Purchase(P)Direct15K shares at avg. $5.85$88K - Jun 23, 2026TOI
Oncology Institute, Inc.
Purchase(P)Direct18K shares at avg. $5.02$90K - Jun 4, 2026TOI
Oncology Institute, Inc.
Purchase(P)Direct12K shares at avg. $4.75$57K - May 20, 2026TOI
Oncology Institute, Inc.
Purchase(P)Direct33.5K shares at avg. $4.07$136K - May 19, 2026TOI
Oncology Institute, Inc.
Purchase(P)Direct5K shares at avg. $4.05$20K - May 19, 2026STIM
Neuronetics, Inc.
Purchase(P)Direct100K shares at avg. $1.17$117K - May 19, 2026TOI
Oncology Institute, Inc.
Purchase(P)Direct30K shares at avg. $4.09$123K - May 12, 2026STIM
Neuronetics, Inc.
Purchase(P)Direct475K shares at avg. $1.34$637K - Apr 21, 2026STIM
Neuronetics, Inc.
Purchase(P)Direct100K shares at avg. $1.51$151K - Apr 20, 2026STIM
Neuronetics, Inc.
Purchase(P)Direct100K shares at avg. $1.58$158K - Apr 17, 2026AIRS
Airsculpt Technologies, Inc.
Expiration(E)DirectCall Option (AIRS 17APR26 $5C)
2K shares- - Apr 17, 2026AIRS
Airsculpt Technologies, Inc.
Purchase(P)Direct40K shares at avg. $2.54$102K - Apr 17, 2026AIRS
Airsculpt Technologies, Inc.
Expiration(E)DirectCall Option (AIRS 17APR26 $4C)
2K shares- - Apr 14, 2026AIRS
Airsculpt Technologies, Inc.
Purchase(P)Direct20K shares at avg. $2.60$52K - Apr 9, 2026TOI
Oncology Institute, Inc.
Purchase(P)Direct20K shares at avg. $3.10$62K - Apr 7, 2026AIRS
Airsculpt Technologies, Inc.
Purchase(P)Direct60K shares at avg. $2.93$176K - Apr 3, 2026AIRS
Airsculpt Technologies, Inc.
Purchase(P)Direct90K shares at avg. $2.82$254K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 30, 2026 |  STIM Neuronetics, Inc. | Purchase(P) | 18,000 | $2.27 | $40,860 | Direct |
| Oct 19, 2026 |  XGN EXAGEN INC. | Purchase(P) | 14,000 | $7.46 | $104,440 | Direct |
| Aug 14, 2026 | STIM Neuronetics, Inc. | Purchase(P) | 14,000 | $3.16 | $44,240 | Direct |
| Aug 14, 2026 |  STLN Starling Oncology, Inc. | Purchase(P) | 12,000 | $6.54 | $78,480 | Direct |
| Aug 13, 2026 | STIM Neuronetics, Inc. | Sale(S) Call Option (STIM 19FEB27 $5C) | 100 | $3.21 | - | Direct |
| Aug 13, 2026 | STLN Starling Oncology, Inc. | Sale(S) Call Option (STLN 19FEB27 $9C) | 100 | $6.24 | - | Direct |
| Jul 21, 2026 |  TOI Oncology Institute, Inc. | Purchase(P) | 18,000 | $5.27 | $94,860 | Direct |
| Jul 14, 2026 | STIM Neuronetics, Inc. | Purchase(P) | 35,000 | $1.78 | $62,300 | Direct |
| Jul 10, 2026 | TOI Oncology Institute, Inc. | Purchase(P) | 15,000 | $5.85 | $87,750 | Direct |
| Jun 23, 2026 | TOI Oncology Institute, Inc. | Purchase(P) | 18,000 | $5.02 | $90,360 | Direct |
| Jun 4, 2026 | TOI Oncology Institute, Inc. | Purchase(P) | 12,000 | $4.75 | $57,000 | Direct |
| May 20, 2026 | TOI Oncology Institute, Inc. | Purchase(P) | 33,500 | $4.07 | $136,345 | Direct |
| May 19, 2026 | TOI Oncology Institute, Inc. | Purchase(P) | 5,000 | $4.05 | $20,250 | Direct |
| May 19, 2026 | STIM Neuronetics, Inc. | Purchase(P) | 100,000 | $1.17 | $117,000 | Direct |
| May 19, 2026 | TOI Oncology Institute, Inc. | Purchase(P) | 30,000 | $4.09 | $122,700 | Direct |
| May 12, 2026 | STIM Neuronetics, Inc. | Purchase(P) | 475,000 | $1.34 | $636,500 | Direct |
| Apr 21, 2026 | STIM Neuronetics, Inc. | Purchase(P) | 100,000 | $1.51 | $151,000 | Direct |
| Apr 20, 2026 | STIM Neuronetics, Inc. | Purchase(P) | 100,000 | $1.58 | $158,000 | Direct |
| Apr 17, 2026 |  AIRS Airsculpt Technologies, Inc. | Expiration(E) Call Option (AIRS 17APR26 $5C) | 2,000 | - | - | Direct |
| Apr 17, 2026 | AIRS Airsculpt Technologies, Inc. | Purchase(P) | 40,000 | $2.54 | $101,600 | Direct |
| Apr 17, 2026 | AIRS Airsculpt Technologies, Inc. | Expiration(E) Call Option (AIRS 17APR26 $4C) | 2,004 | - | - | Direct |
| Apr 14, 2026 | AIRS Airsculpt Technologies, Inc. | Purchase(P) | 20,000 | $2.60 | $52,000 | Direct |
| Apr 9, 2026 | TOI Oncology Institute, Inc. | Purchase(P) | 20,000 | $3.10 | $62,000 | Direct |
| Apr 7, 2026 | AIRS Airsculpt Technologies, Inc. | Purchase(P) | 60,000 | $2.93 | $175,800 | Direct |
| Apr 3, 2026 | AIRS Airsculpt Technologies, Inc. | Purchase(P) | 90,000 | $2.82 | $253,800 | Direct |
1-25 of 50 transactions
About Chernett Jorey
Chernett Jorey (SEC CIK 0002042077) files insider reports with the SEC as 10% Owner of Neuronetics, Inc. (STIM), 10% Owner of EXAGEN INC. (XGN) and 10% Owner of Starling Oncology, Inc. (STLN). Signal8 also holds filings tied to 1 other company.
Signal8 holds 42 ownership filings by Chernett Jorey (4 Form 3, 38 Form 4), filed between Mar 4, 2026 and Nov 2, 2026. Those filings report 50 transactions, from Mar 3, 2026 to Oct 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Chernett Jorey's filings is in BLOOMFIELD HILLS, MI.
Recent filings by Chernett Jorey
- Oct 30, 2026: Open-market purchase of STIM shares (Form 4, code P).
- Oct 19, 2026: Open-market purchase of XGN shares (Form 4, code P).
- Aug 14, 2026: Open-market purchase of STIM shares (Form 4, code P).
- Aug 14, 2026: Open-market purchase of STLN shares (Form 4, code P).
- Aug 13, 2026: Open-market sale of STIM derivative securities (Form 4, code S).
Other insiders filing for Neuronetics, Inc. (STIM)
- Naor Nir, EVP, CFO & Treasurer
- Anderson Cory, EVP & Gen. Manager, Greenbrook
- Amin Avinash, Director
- Madryn Asset Management, LP, 10% Owner
- Rosengarten Megan, Director
- MUIR GLENN P, Director